BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2600187)

  • 1. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

  • 4. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulant medication and the hyperactive adolescent: myths and facts.
    Clampit MK; Pirkle JB
    Adolescence; 1983; 18(72):811-22. PubMed ID: 6666706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hyperkinetic child: current status.
    Dubey DR
    Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulant medication and short attention span: a clinical approach.
    Davy T; Rodgers CL
    J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulant medication and parent training therapies for attention deficit-hyperactivity disorder.
    Anastopoulos AD; DuPaul GJ; Barkley RA
    J Learn Disabil; 1991 Apr; 24(4):210-8. PubMed ID: 1875156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stimulant medication on learning in children with ADHD.
    Swanson JM; Cantwell D; Lerner M; McBurnett K; Hanna G
    J Learn Disabil; 1991 Apr; 24(4):219-30, 255. PubMed ID: 1875157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR
    Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
    Zametkin AJ; Linnoila M; Karoum F; Sallee R
    Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.